MedPath

GUERBET ASIA PACIFIC LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

PPB:14

Drug Approvals

XENETIX 300 SOLUTION FOR INJECTION 300MG I/ML IN 500ML BAG

Approval Date
Nov 17, 2014
PPB

XENETIX 350 SOLUTION FOR INJECTION 350MG I/ML IN 500ML BAG

Approval Date
Nov 17, 2014
PPB

XENETIX 300 SOLUTION FOR INJECTION 300MG I/ML IN 100ML BAG

Approval Date
Nov 17, 2014
PPB

XENETIX 350 SOLUTION FOR INJECTION 350MG I/ML IN 100ML BAG

Approval Date
Nov 17, 2014
PPB

PATENT BLUE V INJ 2.5%

Approval Date
Apr 7, 1998
PPB

DOTAREM INJ. 377MG/ML (VIAL)

Approval Date
Dec 11, 1996
PPB

DOTAREM PREFILLED SYRINGES, 377MG/ML

Approval Date
Dec 11, 1996
PPB

XENETIX 350 INJ 350MG/ML

Approval Date
Sep 27, 1996
PPB

XENETIX 300 INJ 300MG/ML

Approval Date
Sep 27, 1996
PPB

OPTIRAY-350 INJ 74%

Approval Date
Feb 16, 1995
PPB
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.